Clearbridge Health Limited announced that the Company has appointed ZICO Capital Pte. Ltd. as its new continuing sponsor with effect from 8 March 2024, in place of the current continuing sponsor, United Overseas Bank Limited . The change of continuing sponsor is due to commercial reasons.

Pursuant to Rule 228(5) of the Singapore Exchange Securities Trading Limited (the SGX-ST) Listing Manual Section B: Rules of Catalist, UOB, as the current continuing sponsor of the Company, has confirmed that as at the date of this announcement, it is not aware of any non-compliance with the Catalist Rules by the Company that has not been brought to the attention of ZICO. UOB has also made itself available for discussion with ZICO as required under Rule 228(3) of the Catalist Rules. UOB shall remain as the Sponsor until 7 March 2024.